DINSMORE CHRISTOPHER (Chief Scientific Officer) sold 2.2% of their position (6.29K shares) of KRONOS BIO, INC. on the open market
Open‑market sale worth $10.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2023ACC: 0001209191-23-013017
Officer· Chief Scientific Officer
Since Oct 2020
-6.29K
Net shares
Net seller
$10.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.29K
Price / share
$1.74
Trade value
$10.92K
% of position
2.2%
2/24/2023
291.29K→285K
Total
Net shares
−6.29K
Net value
-$10.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2023 | S · Sale | −6.29K | $1.74 | $10.92K | 2.2% | 291.29K | 285K |
| Total | −6.29K | -$10.92K | ||||||
Derivative Transactions0
No derivative transactions reported